Plunkett Research Online: BioInvent International AB

BIOINVENT INTERNATIONAL AB (BOVNF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioInvent International AB is engaged in developing antibody-based drugs to treat haematological cancers, as well as therapies, by affecting normal blood cells. The Company's product include; BI-505, BI-1206, n-CoDeR, F.I.R.S.T. and TB-403......



BioInvent International AB
Ticker: BOVNF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 46 462868550
Fax: 46 462110806
Address: Solvegatan 41
Lund, 223 70 Sweden

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

BioInvent International AB is engaged in developing antibody-based drugs to treat haematological cancers, as well as therapies, by affecting normal blood cells. The Company's product include; BI-505, BI-1206, n-CoDeR, F.I.R.S.T. and TB-403......See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: